Travis Manni

People with Type 1 can electronically sign up for the T1D Exchange Living BioBank to be considered for future studies.

The device delivers unreliable vital signs in certain conditions.

There have been poor launch sales of the new inhalable insulin system. Can it rebound?

Regulators are requiring all multi-dose pens be labeled “For single patient use only”.

38% of women with Type 1 over the age of 65 have osteoporosis or osteopenia.

European testing will begin for the Mendor Smart, a device that uses cloud storage for blood glucose readings.

Researchers find the pump’s Threshold Suspend feature works well in a real world setting, according to company-funded study.

Multiple studies have shown that women die younger than men with the condition.

The drug can now be used to treat diabetic macular edema.

The insulin automatically stabilized high blood-sugar in mice with diabetes.

A study suggests that a severe lack of bacteria in stomachs of toddlers could signal a future Type 1 diagnosis.

Microcapsules inserted beneath the skin of mice slowly released insulin after being exposed to micro-shockwaves.

This announcement comes on the heels of news that it has gained FDA approval to market a blood-sugar data sharing…

People with diabetes spend $2,790 a year more to stay healthy than they those with diabetes did 20 years ago.

A study shows that doctors might be able to diagnose future eye problems by looking at nerve cells in the…

The FDA approves the marketing of CGM mobile apps that can collect and share blood-glucose readings.

Tattoo CGMs, Afrezza news, Dexcom profits, Medtronic’s merger.